Table 1.
MTS assay | Cytotoxicity enhanced | Cytotoxicity attenuated | Cytotoxicity unchanged |
---|---|---|---|
Initial screen | 48 | 32 | 21 |
Validationa | 21 | 20 | 4 |
aOnly 45 drugs available for the validation screen
MDA-MB-231 cells were treated with individual drugs (101 anticancer drugs, the NCI Oncology Set IV) at IC25 and IC50 drug concentrations, and DHA (at 50 μM for initial screen and 25, 50, and 100 μM for validation) for 48 h. Cell viability was determined by MTS assay